Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 6/2022

Inhalt (20 Artikel)

Molecular imaging of cellular immunotherapies in experimental and therapeutic settings

  • Open Access
  • Review

Nourhan Shalaby, Veronica Phyllis Dubois, John Ronald

Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma

  • Original Article

Kui Cao, Mingdong Liu, Keru Ma, Xiangyu Jiang, Jianqun Ma, Jinhong Zhu

Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer

  • Open Access
  • Original Article

Jun-Nan Guo, Du Chen, Shen-Hui Deng, Jia-Rong Huang, Jin-Xuan Song, Xiang-Yu Li, Bin-Bin Cui, Yan-Long Liu

Cyclic sulfur compounds targeting macrophage polarization into M2/protumor phenotype and their anti-tumor effects

  • Original Article

Cheng Pan, Yukio Fujiwara, Hasita Horlad, Toyohisa Iriki, Daisuke Shiraishi, Yoshihiro Komohara

First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis

  • Original Article

Mingfeng He, Taihao Zheng, Xiaoyue Zhang, Yuan Peng, Xuan Jiang, Yusheng Huang, Benxu Tan, Zhenzhou Yang

PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer

  • Original Article

Miho Takahashi, Satoshi Watanabe, Ryo Suzuki, Masashi Arita, Ko Sato, Miyuki Sato, Yuki Sekiya, Yuko Abe, Toshiya Fujisaki, Aya Ohtsubo, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Yu Saida, Satoshi Hokari, Nobumasa Aoki, Masachika Hayashi, Yasuyoshi Ohshima, Toshiyuki Koya, Toshiaki Kikuchi

CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein–Barr virus genes

  • Open Access
  • Original Article

Semjon Sidorov, Lara Fux, Katja Steiner, Samyo Bounlom, Sabrina Traxel, Tarik Azzi, Arbeneshe Berisha, Christoph Berger, Michele Bernasconi, Felix K. Niggli, Yvonne Perner, Sugeshnee Pather, Werner Kempf, David Nadal, Simone Bürgler

Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study

  • Original Article

Jin-Ji Yang, Cheng Huang, Yun Fan, Hongming Pan, Jifeng Feng, Liyan Jiang, Xing-Ya Li, Xiao-Qing Liu, Jian-Ping Xiong, Yan-Qiu Zhao, Ying Cheng, Rui Ma, Jie Wang, Yina Wang, Yan-Hui Liu, Dong-Mei Lin, Tao Wang, Wei Shi, Jianjun Zou, Yi-Long Wu

Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy

  • Open Access
  • Original Article

Defeng Jiao, Xiaohu Zheng, Xianghui Du, Dong Wang, Ziming Hu, Rui Sun, Zhigang Tian, Binqing Fu, Haiming Wei

Efficacy and safety of Wilms’ tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial

  • Original Article

Toru Kiguchi, Masaki Yamaguchi, Naoki Takezako, Shuichi Miyawaki, Koichi Masui, Yuichiro Ihara, Masao Hirota, Naoko Shimofurutani, Tomoki Naoe

Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer

  • Open Access
  • Original Article

Meng Qin, Junzo Hamanishi, Masayo Ukita, Koji Yamanoi, Shiro Takamatsu, Kaoru Abiko, Ryusuke Murakami, Taito Miyamoto, Haruka Suzuki, Akihiko Ueda, Yuko Hosoe, Akihito Horie, Ken Yamaguchi, Masaki Mandai

Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study

  • Open Access
  • Original Article

Kaili Yang, Lu Han, Shikai Wu, Xiujuan Qu, Qin Li, Chuanhua Zhao, Jing Zhou, Xuan Jin, Yusheng Wang, Dong Yan, Zhiqiang Cheng, Yuwei Hua, Yan Zhang, Yang Ge, Jinghua Sun, Wei Deng, Lin Zhao, Yunbo Zhao

PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival

  • Open Access
  • Original Article

Kelley G. Núñez, Tyler Sandow, Daniel Fort, Mina Hibino, Paige Wright, Ari J. Cohen, Paul T. Thevenot

Clinical determinants of long-term survival in metastatic uveal melanoma

  • Open Access
  • Original Article

Elias A. T. Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Michael Erdmann, Lucie Heinzerling, Bettina Hohberger, Harald Knorr, Ulrike Leiter, Friedegund Meier, Peter Mohr, Farnaz Rahimi, Beatrice Schell, Max Schlaak, Patrick Terheyden, Beatrice Schuler-Thurner, Selma Ugurel, Jochen Utikal, Julio Vera, Michael Weichenthal, Fabian Ziller, Carola Berking, Markus V. Heppt

Comprehensive characterization of tumor immune landscape following oncolytic virotherapy by single-cell RNA sequencing

  • Original Article

Divya Ravirala, Guangsheng Pei, Zhongming Zhao, Xiaoliu Zhang

Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer

  • Original Article

Mengmeng Sun, Han Zeng, Kaifeng Jin, Zhaopei Liu, Baoying Hu, Chunnan Liu, Sen Yan, Yanze Yu, Runze You, Hongyi Zhang, Yuan Chang, Li Liu, Yu Zhu, Jiejie Xu, Le Xu, Zewei Wang

Intravesical Pseudomonas aeruginosa mannose-sensitive Hemagglutinin vaccine triggers a tumor-preventing immune environment in an orthotopic mouse bladder cancer model

  • Original Article

Bo Wang, Zhihua He, Hao Yu, Ziwei Ou, Junyu Chen, Meihua Yang, Xinxiang Fan, Tianxin Lin, Jian Huang

Prognostic value of preoperative soluble interleukin 2 receptor α as a novel immune biomarker in epithelial ovarian cancer

  • Original Article

Hui Li, Miaofang Wu, Zhuna Wu, Jinxiao Liang, Lijuan Wang, Xi Yang, Zhongqiu Lin, Jing Li

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit

  • Clinical Trial Report

Emily Nickles, Bhushan Dharmadhikari, Li Yating, Robert J. Walsh, Liang Piu Koh, Michelle Poon, Lip Kun Tan, Ling-Zhi Wang, Yvonne Ang, Yugarajah Asokumaran, Wan Qin Chong, Yiqing Huang, Kwok Seng Loh, Joshua Tay, Ross Soo, Mickey Koh, Liam Pock Ho, Marieta Chan, Madelaine Niam, Melissa Soh, Yen Hoon Luah, Chwee Ming Lim, Nivashini Kaliaperumal, Veonice B. Au, Najwa Binte Said Nasir Talib, Reina Sng, John E. Connolly, Boon Cher Goh, Herbert Schwarz

Anogenital lichen sclerosus et atrophicus lesions in a case series of cancer patients on immunotherapy

  • Research Report

V. Conteduca, M. Medri, L. Mazzoni, U. De Giorgi, I. Stanganelli

Neu im Fachgebiet Onkologie

ctDNA erkennt minimale Resterkrankung beim Melanom

Die Diagnose einer minimalen Resterkrankung mithilfe zirkulierender Tumor-DNA könnte (ctDNA) auch das Management von Patientinnen und Patienten mit Melanomen im Stadium III bereichern, wie Ergebnisse einer Studie nahelegen – auch wenn die Methode noch nicht perfekt funktioniert.

Höhere Dosis von Dexamethason senkt Überlebenschancen

Personen mit Hirnmetastasen, die perioperativ höhere kumulative Dosen von Dexamethason erhalten, haben eine schlechtere Prognose. Um die Ergebnisse zu verbessern, bedarf es strengerer Dosierungsschemata.

Ringen um den richtigen Umgang mit Zufallsbefunden

Wenn 2026 in Deutschland das Lungenkrebsscreening mittels Low-Dose-Computertomografie (LDCT) eingeführt wird, wird es auch viele Zufallsbefunde ans Licht bringen. Das birgt Chancen und Risiken.

Bald 5% der Krebserkrankungen durch CT verursacht

Die jährlich rund 93 Millionen CTs in den USA könnten künftig zu über 100.000 zusätzlichen Krebserkrankungen führen, geht aus einer Modellrechnung hervor. Damit würde eine von 20 Krebserkrankungen auf die ionisierende Strahlung bei CT-Untersuchungen zurückgehen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.